Skip to main content

Business

By HIMSS TV | 11:28 am | November 15, 2024
Dr. Keisuke Nakagawa, director of innovation at UC Davis Health, highlights how artificial intelligence can help unearth social determinants of health and how AI can advance health equity.  
By Anthony Vecchione | 12:33 pm | November 14, 2024
The company will use the funds to strengthen its research and development capabilities.  
By Anthony Vecchione | 02:38 pm | November 13, 2024
The aim of the acquisitions is to accelerate the company's involvement in two major growth areas and improve patient care.  
By HIMSS TV | 06:17 pm | November 12, 2024
Third-party risk management was the No. 1 weak link reported in organizations' cyberdefense strategies, says Jill Brewer, market insights lead at HIMSS. The No. 1 technology to use is AI-powered threat-detection and analytics.  
By HIMSS TV | 04:55 pm | November 12, 2024
Richard Staynings, a University of Denver professor, highlights the drawbacks and benefits of AI in patient care and precision medicine, advancing cybersecurity in healthcare, and malicious use of the technology to get past malware defenses.
By Jessica Hagen | 06:50 pm | November 11, 2024
According to Bloomberg, the brain-implant chipmaker raised $93 million in funding, increasing the startup's valuation to approximately $500 million.
By HIMSS TV | 10:43 am | November 11, 2024
Anurag Mehta, CEO and cofounder of Omega Healthcare, discusses the reasons for clinician and staff burnout and virtual nursing's role in easing providers’ duties, including responding to digital messages and completing EHR tasks.
By Anthony Vecchione | 04:20 pm | November 08, 2024
DarioHealth, Clover Health and eHealth also released third-quarter financial results.  
By Anthony Vecchione | 04:12 pm | November 08, 2024
HATCo will spend a total of $550 million in capital funding to invest in technologies and innovation.
By HIMSS TV | 10:48 am | November 08, 2024
Adam Hutchinson, oVRcome founder and CEO, discusses reducing phobias using VR exposure therapy, how the company fills the gap in VR psychiatric care access for providers and patients, and its trial on combatting social anxiety with VR.